Clinical Trial Update: Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial [Phase 4]

View source ↗

Summary

A Phase 4 double-blind, placebo-controlled trial evaluating aripiprazole for methamphetamine dependence was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Methamphetamine Dependence | Phase 4 | Status: WITHDRAWN